Jun. 29 at 2:49 PM
$FATE In my opinion Fate Therapeutics is positioned to potentially be worth multi billions. Moderna is set to launched a similar off the shelf trial scheduled for 2027. Despite them being a competitor this proves that this market is of major interest to big Pharma . Do not be surprised if the stock price goes on a massive run in the future because this company is designed to sell. When you look at their board and their largest holders like Red Mile Group William Rastetter and the new board member Laura Hamill who most recently sold Acceleron Pharma you see they are absolute experts in this field when it comes to selling companies. This stock may not run until the phase two trials are launched or the results are in but make no mistake that the company is definitely designed to sell and has major potential if the phase-2 trails are a win. However, the weight could be as long as next summer depending on the companies direction.
